MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.
Zhang KL, Zhou X, Han L, Chen LY, Chen LC, Shi ZD, Yang M, Ren Y, Yang JX, Frank TS, Zhang CB, Zhang JX, Pu PY, Zhang JN, Jiang T, Wagner EJ, Li M, Kang CS.
Zhang KL, et al.
Mol Cancer. 2014 Mar 20;13:63. doi: 10.1186/1476-4598-13-63.
Mol Cancer. 2014.
PMID: 24650032
Free PMC article.